Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 71 citing articles:

Theoretical understanding of evolutionary dosing following tumor dynamics
M. A. Masud, Eunjung Kim
Chaos Solitons & Fractals (2024) Vol. 179, pp. 114451-114451
Open Access | Times Cited: 2
Deep reinforcement learning identifies personalized intermittent androgen deprivation therapy for prostate cancer
Yitao Lu, Qian Chu, Zhen Li, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 2
Open Access | Times Cited: 2
Evolutionary double-bind treatment using radiotherapy and NK cell-based immunotherapy in prostate cancer
Kimberly A. Luddy, Jeffrey West, Mark Robertson‐Tessi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Adaptive Cancer Therapy in the Age of Generative Artificial Intelligence
Youcef Derbal
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
How We Treat Metastatic Castration-Sensitive Prostate Cancer
Filip Ionescu, Jingsong Zhang
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
The effect of tumor composition on the success of adaptive therapy: The case of metastatic Castrate-Resistant Prostate Cancer
Mónica L. Salvioli, Len Vandelaer, Esther Baena, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0308173-e0308173
Open Access | Times Cited: 2
A mathematical framework for comparison of intermittent versus continuous adaptive chemotherapy dosing in cancer
Cordelia D. McGehee, Yoichiro Mori
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Stackelberg Evolutionary Games of Cancer Treatment: What Treatment Strategy to Choose if Cancer Can be Stabilized?
Mónica L. Salvioli, Hasti Garjani, Mohammadreza Satouri, et al.
Dynamic Games and Applications (2024)
Open Access | Times Cited: 2
Intermetastatic and Intrametastatic Heterogeneity Shapes Adaptive Therapy Cycling Dynamics
Jill Gallaher, Maximilian Strobl, Jeffrey West, et al.
Cancer Research (2023) Vol. 83, Iss. 16, pp. 2775-2789
Open Access | Times Cited: 6
A Phase 1b Adaptive Androgen Deprivation Therapy Trial in Metastatic Castration Sensitive Prostate Cancer
Jingsong Zhang, Jill Gallaher, Jessica J. Cunningham, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5225-5225
Open Access | Times Cited: 10
Evolutionary determinants of curability in cancer
Marcela Braga Mansur, Nandita M. deSouza, Rachael Natrajan, et al.
Nature Ecology & Evolution (2023) Vol. 7, Iss. 11, pp. 1761-1770
Closed Access | Times Cited: 5
A Mathematical Framework for Comparison of Intermittent versus Continuous Adaptive Chemotherapy Dosing in Cancer
Cordelia D. McGehee, Yoichiro Mori
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A resource-based mechanistic framework for castration-resistant prostate cancer (CRPC)
B. Vibishan, Harshavardhan B.V., Sutirth Dey
Journal of Theoretical Biology (2024) Vol. 587, pp. 111806-111806
Open Access | Times Cited: 1
Dynamic analysis of a drug resistance evolution model with nonlinear immune response
Tengfei Wang, Xiufen Zou
Mathematical Biosciences (2024) Vol. 374, pp. 109239-109239
Closed Access | Times Cited: 1
Understanding patient-derived tumor organoid growth through an integrated imaging and mathematical modeling framework
Einar Bjarki Gunnarsson, Seungil Kim, Brandon Choi, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 8, pp. e1012256-e1012256
Open Access | Times Cited: 1
Validation of polymorphic Gompertzian model of cancer throughin vitroandin vivodata
Arina Soboleva, Artem Kaznatcheev, Rachel Cavill, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Effective dose window for containing tumor burden under tolerable level
M. A. Masud, Jae‐Young Kim, Eunjung Kim
npj Systems Biology and Applications (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Convergent TP53 loss and evolvability in cancer
Marcela Braga Mansur, Mel Greaves
BMC Ecology and Evolution (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Range-Bounded Adaptive Therapy in Metastatic Prostate Cancer
Renee Brady‐Nicholls, Heiko Enderling
Cancers (2022) Vol. 14, Iss. 21, pp. 5319-5319
Open Access | Times Cited: 6
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous proteasome inhibitor resistant disease
Ryan T. Bishop, Anna Miller, Matthew Froid, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Modeling the effect of acquired resistance on cancer therapy outcomes
M. A. Masud, Jae‐Young Kim, Eunjung Kim
Computers in Biology and Medicine (2023) Vol. 162, pp. 107035-107035
Closed Access | Times Cited: 3
Evolutionary Games and Applications: Fifty Years of ‘The Logic of Animal Conflict’
Christian Hilbe, Maria Kleshnina, Kateřina Staňková
Dynamic Games and Applications (2023) Vol. 13, Iss. 4, pp. 1035-1048
Open Access | Times Cited: 3
A novel cell line panel reveals non-genetic mediators of platinum resistance and phenotypic diversity in high grade serous ovarian cancer
Joseph Hoare, Helen Hockings, Jayeta Saxena, et al.
Gynecologic Oncology (2022) Vol. 167, Iss. 1, pp. 96-106
Open Access | Times Cited: 5
High Accuracy Indicators of Androgen Suppression Therapy Failure for Prostate Cancer—A Modeling Study
William Meade, Allison Weber, Tin Phan, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4033-4033
Open Access | Times Cited: 4
The prognostic value of androgen to PSA ratio in predictive modeling of prostate cancer
Tin Phan, Allison Weber, Alan H. Bryce, et al.
Medical Hypotheses (2023) Vol. 176, pp. 111084-111084
Closed Access | Times Cited: 2

Scroll to top